Generate Better Drug Discovery Data, Faster.

SAMDI Tech, a Charles River company, leads the industry with an innovative approach to drug discovery. Gain confidence in your data and make smarter go or no-go decisions with solutions from our rapid, quantitative, label-free SAMDI technology and assay formats beyond label-free.

SAMDI (Self-Assembled Monolayer Desorption Ionization) technology was first described by Dr. Milan Mrksich in 2002 as a solution to the challenges and pitfalls of label-dependent biochemical assays. Dr. Mrksich found that self-assembled monolayers (SAMs) could be analyzed by Matrix Assisted Laser Desorption/Ionization (MALDI) mass spectrometry, a key discovery that provided the foundation for the label-free and high-throughput SAMDI assay.

In 2011, Dr. Mrksich founded SAMDI Tech to provide researchers an opportunity to benefit from SAMDI technology for diverse drug discovery applications.

At SAMDI Tech, we believe in better, faster results. Contact our team to learn more about how SAMDI technology can advance your drug discovery pipeline.